Myomo Inc (MYO) - Net Assets
Based on the latest financial reports, Myomo Inc (MYO) has net assets worth $9.00 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($36.75 Million) and total liabilities ($27.75 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Myomo Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $9.00 Million |
| % of Total Assets | 24.49% |
| Annual Growth Rate | 28.67% |
| 5-Year Change | -26.0% |
| 10-Year Change | N/A |
| Growth Volatility | 212.76 |
Myomo Inc - Net Assets Trend (2014–2025)
This chart illustrates how Myomo Inc's net assets have evolved over time, based on quarterly financial data. Also explore Myomo Inc (MYO) total assets for the complete picture of this company's asset base.
Annual Net Assets for Myomo Inc (2014–2025)
The table below shows the annual net assets of Myomo Inc from 2014 to 2025. For live valuation and market cap data, see MYO company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $11.40 Million | -53.86% |
| 2024-12-31 | $24.71 Million | +174.93% |
| 2023-12-31 | $8.99 Million | +41.36% |
| 2022-12-31 | $6.36 Million | -58.73% |
| 2021-12-31 | $15.41 Million | +33.24% |
| 2020-12-31 | $11.57 Million | +533.82% |
| 2019-12-31 | $1.82 Million | -71.60% |
| 2018-12-31 | $6.43 Million | -48.37% |
| 2017-12-31 | $12.45 Million | +171.00% |
| 2016-12-31 | $-17.53 Million | -1210.04% |
| 2015-12-31 | $-1.34 Million | -287.91% |
| 2014-12-31 | $712.11K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Myomo Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 10315969800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.85K | 0.03% |
| Other Comprehensive Income | $164.52K | 1.44% |
| Other Components | $129.92 Million | 1139.33% |
| Total Equity | $11.40 Million | 100.00% |
Myomo Inc Competitors by Market Cap
The table below lists competitors of Myomo Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GeneReach Biotechnology
TWO:4171
|
$32.86 Million |
|
Viomi Technology ADR
NASDAQ:VIOT
|
$32.88 Million |
|
Quonia SOCIMI SA
MC:YQUO
|
$32.88 Million |
|
RedCloud Holdings plc Ordinary Shares
NASDAQ:RCT
|
$32.90 Million |
|
Samhwa Crown
KO:004450
|
$32.84 Million |
|
Good Way Technology Co Ltd
TWO:3272
|
$32.84 Million |
|
Toplus Global Co Ltd
TWO:3522
|
$32.81 Million |
|
Dongil Metal Co. Ltd
KQ:109860
|
$32.79 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Myomo Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 24,714,057 to 11,403,467, a change of -13,310,590 (-53.9%).
- Net loss of 15,573,884 reduced equity.
- Other comprehensive income increased equity by 178,923.
- Other factors increased equity by 2,084,371.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-15.57 Million | -136.57% |
| Other Comprehensive Income | $178.92K | +1.57% |
| Other Changes | $2.08 Million | +18.28% |
| Total Change | $- | -53.86% |
Book Value vs Market Value Analysis
This analysis compares Myomo Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.49x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.04x to 3.49x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $21.40 | $0.95 | x |
| 2015-12-31 | $-40.17 | $0.95 | x |
| 2016-12-31 | $-2.73 | $0.95 | x |
| 2017-12-31 | $86.47 | $0.95 | x |
| 2018-12-31 | $15.67 | $0.95 | x |
| 2019-12-31 | $3.29 | $0.95 | x |
| 2020-12-31 | $3.47 | $0.95 | x |
| 2021-12-31 | $2.64 | $0.95 | x |
| 2022-12-31 | $0.90 | $0.95 | x |
| 2023-12-31 | $0.30 | $0.95 | x |
| 2024-12-31 | $0.65 | $0.95 | x |
| 2025-12-31 | $0.27 | $0.95 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Myomo Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -136.57%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -38.05%
- • Asset Turnover: 1.06x
- • Equity Multiplier: 3.39x
- Recent ROE (-136.57%) is above the historical average (-160.70%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -495.40% | -386.29% | 0.30x | 4.28x | $-3.60 Million |
| 2015 | 0.00% | -649.90% | 0.46x | 0.00x | $-4.35 Million |
| 2016 | 0.00% | -327.84% | 0.67x | 0.00x | $-1.86 Million |
| 2017 | -97.20% | -776.04% | 0.11x | 1.12x | $-13.34 Million |
| 2018 | -160.55% | -422.11% | 0.30x | 1.29x | $-10.96 Million |
| 2019 | -587.11% | -279.15% | 0.58x | 3.62x | $-10.90 Million |
| 2020 | -99.99% | -152.49% | 0.52x | 1.27x | $-12.72 Million |
| 2021 | -67.31% | -74.86% | 0.69x | 1.30x | $-11.91 Million |
| 2022 | -168.59% | -68.92% | 1.53x | 1.60x | $-11.36 Million |
| 2023 | -90.64% | -42.34% | 1.32x | 1.62x | $-9.05 Million |
| 2024 | -25.02% | -19.00% | 0.77x | 1.71x | $-8.66 Million |
| 2025 | -136.57% | -38.05% | 1.06x | 3.39x | $-16.71 Million |
Industry Comparison
This section compares Myomo Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $757,800,566
- Average return on equity (ROE) among peers: -54.77%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Myomo Inc (MYO) | $9.00 Million | -495.40% | 3.08x | $32.84 Million |
| Abbott Laboratories (ABT) | $7.43 Billion | 32.93% | 0.95x | $152.62 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $18.77 Million |
| Aethlon Medical Inc (AEMD) | $-7.09 Million | 0.00% | 0.00x | $2.76 Million |
| Acutus Medical Inc (AFIB) | $75.02 Million | -52.81% | 0.78x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $6.89 Million | 30.07% | 0.49x | $12.47 Million |
| Allurion Technologies, Inc. (ALUR) | $19.83K | -26.07% | 15.64x | $9.70 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $8.10 Million | -140.88% | 0.21x | $3.99 Million |
| Artivion Inc (AORT) | $30.20 Million | 15.56% | 0.78x | $1.11 Billion |
| Apyx Medical Inc (APYX) | $2.22 Million | 4.46% | 0.72x | $153.68 Million |
About Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more